SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

JB Chemicals gets its shareholders’ nod to sell OTC biz in Russia and CIS countries

11 Jul 2011 Evaluate

JB Chemicals & Pharmaceuticals (JBCPL) has received its shareholder’ for the sale of its over-the-counter business in Russia and CIS countries to Johnson & Johnson subsidiary Cilag GmbH for a consideration of Rs 938 crore.

The shareholders’ approval for the agreement follows the nod given to the pact by the board of directors in May this year.

The Russia/CIS (Commonwealth of Independent States) OTC business is being sold as a going concern on a slump sale basis, including trademarks, brand, patents, registrations and domain names, the company had said in an earlier statement

Recently, the company had launched its new -- Femident Division -- catering to Gynecology and Dental products, in its domestic formulations business. The company has launched this division with over 100 medical representatives and 15 products some of which are first of its kind in its respective segment

JBCPL is one of India’s leading pharmaceutical companies which manufacture and markets a diverse range of pharmaceutical formulations, herbal remedies and APIs.

JB Chem & Pharma Share Price

1997.35 22.65 (1.15%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×